These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12013977)

  • 1. [Primary carnitine deficiency].
    Kuwajima M
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():701-5. PubMed ID: 12013977
    [No Abstract]   [Full Text] [Related]  

  • 2. [Familial carnitine deficiency].
    Yorifuji S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):47-50. PubMed ID: 11596440
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary carnitine deficiency in the Chinese.
    Tang NL; Hui J; Law LK; To KF; Cheung KL; Magnus HN; Yuen PM; Fok TF
    Chin Med J (Engl); 2000 Apr; 113(4):376-80. PubMed ID: 11775240
    [No Abstract]   [Full Text] [Related]  

  • 4. Carnitine transport by organic cation transporters and systemic carnitine deficiency.
    Lahjouji K; Mitchell GA; Qureshi IA
    Mol Genet Metab; 2001 Aug; 73(4):287-97. PubMed ID: 11509010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary carnitine deficiency].
    Kuwajima M
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():706-9. PubMed ID: 12013978
    [No Abstract]   [Full Text] [Related]  

  • 6. Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency.
    Mayatepek E; Nezu J; Tamai I; Oku A; Katsura M; Shimane M; Tsuji A
    Hum Mutat; 2000 Jan; 15(1):118. PubMed ID: 10612840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality.
    Burwinkel B; Kreuder J; Schweitzer S; Vorgerd M; Gempel K; Gerbitz KD; Kilimann MW
    Biochem Biophys Res Commun; 1999 Aug; 261(2):484-7. PubMed ID: 10425211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary carnitine deficiency].
    Yorifuji S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):51-3. PubMed ID: 11596448
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation.
    Wang Y; Taroni F; Garavaglia B; Longo N
    Hum Mutat; 2000 Nov; 16(5):401-7. PubMed ID: 11058897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter.
    Nezu J; Tamai I; Oku A; Ohashi R; Yabuuchi H; Hashimoto N; Nikaido H; Sai Y; Koizumi A; Shoji Y; Takada G; Matsuishi T; Yoshino M; Kato H; Ohura T; Tsujimoto G; Hayakawa J; Shimane M; Tsuji A
    Nat Genet; 1999 Jan; 21(1):91-4. PubMed ID: 9916797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A missense mutation in the OCTN2 gene associated with residual carnitine transport activity.
    Wang Y; Kelly MA; Cowan TM; Longo N
    Hum Mutat; 2000; 15(3):238-45. PubMed ID: 10679939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A founder mutation (R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients.
    Tang NL; Hwu WL; Chan RT; Law LK; Fung LM; Zhang WM
    Hum Mutat; 2002 Sep; 20(3):232. PubMed ID: 12204000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular fibrillation without overt cardiomyopathy as first presentation of organic cation transporter 2-deficiency in adolescence.
    Rijlaarsdam RS; van Spronsen FJ; Bink-Boelkens MT; Reijngoud DJ; Wanders RJ; Niezen-Koning KE; Van der Sluijs FH; Dorland B; Beaufort-Krol GC
    Pacing Clin Electrophysiol; 2004 May; 27(5):675-6. PubMed ID: 15125729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy.
    Lamhonwah AM; Olpin SE; Pollitt RJ; Vianey-Saban C; Divry P; Guffon N; Besley GT; Onizuka R; De Meirleir LJ; Cvitanovic-Sojat L; Baric I; Dionisi-Vici C; Fumic K; Maradin M; Tein I
    Am J Med Genet; 2002 Aug; 111(3):271-84. PubMed ID: 12210323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carnitine transport defect].
    Yoshida I
    Ryoikibetsu Shokogun Shirizu; 2001; (33):337-8. PubMed ID: 11462463
    [No Abstract]   [Full Text] [Related]  

  • 17. Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/carnitine transporter OCTN2.
    Spiekerkoetter U; Huener G; Baykal T; Demirkol M; Duran M; Wanders R; Nezu J; Mayatepek E
    J Inherit Metab Dis; 2003; 26(6):613-5. PubMed ID: 14605509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic difficulties in a case of primary systemic carnitine deficiency with idiopathic dilated cardiomyopathy.
    Kinali M; Olpin SE; Clayton PT; Daubeney PE; Mercuri E; Manzur AY; Tein I; Leonard J; Muntoni F
    Eur J Paediatr Neurol; 2004; 8(4):217-9. PubMed ID: 15261886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases.
    Wasant P; Matsumoto I; Naylor E; Liammongkolkul S
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S710-9. PubMed ID: 12403251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
    Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.